Why BANCO MACRO SA-ADR (NYSE:BMA) qualifies as a high growth stock.

In this article we will dive into BANCO MACRO SA-ADR (NYSE:BMA) as a possible candidate for growth investing. Investors should always do their own research, but we noticed BANCO MACRO SA-ADR showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Looking into the canslim metrics of BANCO MACRO SA-ADR

• With a favorable trend in its quarter-to-quarter (Q2Q) earnings per share (EPS), BMA highlights its ability to generate increasing profitability, showcasing a 1.0K% growth.
• The q2q revenue growth of 139.0% of BMA highlights the company's ability to generate incremental revenue and suggests positive market demand for its products or services.
• Over the past 3 years, BMA has demonstrated 168.0% growth in EPS, signifying its positive financial trajectory and potential for future profitability.
• The Return on Equity (ROE) of BMA stands at 28.16%, reflecting the company's strong profitability and effective utilization of shareholder equity. This metric signifies the company's ability to generate returns for its investors.
• BMA has exhibited strong Relative Strength(RS) in recent periods, with a current 75.77 rating. This indicates the stock's ability to outperform the broader market and reflects its competitive position.
• With a Debt/Equity ratio of 0.13, BMA demonstrates prudent financial management.
• BMA demonstrates a balanced ownership structure, with institutional shareholders at 34.99%. This indicates a diverse investor base, which can contribute to price stability and potential future growth.

Analyzing the Technical Aspects

At ChartMill, a crucial aspect of their analysis is the assignment of a Technical Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous technical indicators and properties.

We assign a technical rating of 2 out of 10 to BMA. Although BMA is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.

• Looking at the yearly performance, BMA did better than 75% of all other stocks. However, BMA's most recent performance is quite weak.
• BMA is part of the Banks industry. There are 403 other stocks in this industry, BMA did better than 54% of them.
• BMA is currently trading in the middle of its 52 week range. This is in line with the S&P500 Index, which is also trading in the middle of its range.
• In the last month BMA has a been trading in the 61.52 - 87.16 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
• Volume is considerably higher in the last couple of days.

Check the latest full technical report of BMA for a complete technical analysis.

Fundamental analysis of BMA

ChartMill assigns a Fundamental Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple fundamental indicators and properties.

BMA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 403 industry peers in the Banks industry. BMA may be in some trouble as it scores bad on both profitability and health. BMA is valued quite expensively, but it does show have an excellent growth rating.

Check the latest full fundamental report of BMA for a complete fundamental analysis.

Our CANSLIM screen will find you more ideas suited for growth investing.

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.